IDXX Q4 2020 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q4 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$721M+19.1% YoY

Gross Profit

$410M56.8% margin

Operating Income

$185M25.7% margin

Net Income

$175M24.2% margin

EPS (Diluted)

$2.01

QoQ Revenue Growth

-0.1%

Cash Flow

Operating Cash Flow

$219M

Free Cash Flow

$205M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$2.3B

Total Liabilities

$1.7B

Stockholders' Equity

$632M

Cash & Equivalents

$384M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$721M	$605M	+19.1%
Gross Profit	$410M	$331M	+23.7%
Operating Income	$185M	$116M	+60.1%
Net Income	$175M	$90M	+93.1%

Revenue Segments

Instrument Rebate Programs

$4M100%

Geographic Segments

UNITED STATES

$434M55%

EMEA

$162M21%

Asia Pacific

$149M19%

CANADA

$29M4%

Latin America

$16M2%